HCW BiologicsHCWB
13F holders, Q2 2025 (June 30)8holders
$3.96avg. 13F price*
At the end of Q2 2025, 8 institutions reported holding HCW Biologics Inc. (HCWB) in their 13F filings. The largest holders were Golden State Wealth Management, LLC ($40K), UBS Group AG ($38K) and Wells Fargo & Company ($7K).
- Company
- HCW Biologics Inc.
- CUSIP
- 40423R204
- Latest filing quarter
- Q1 2026
History
Number of 13F holders
Total Exit/New Position Q2 2025
| Institutions | Total Value | |
|---|---|---|
| New Positions | 8 | $86K |
| Exits | 0 | $0 |
Ownership 8 holders
| Golden State Wealth Management, LLC | 0.00% | New | 10,000 | $40K |
| UBS Group AG | 0.00% | New | 9,518 | $38K |
| Wells Fargo & Company | 0.00% | New | 1,700 | $7K |
| Tower Research Capital LLC (TRC) | 0.00% | New | 250 | $991 |
| Fortitude Family Office, LLC | 0.00% | New | 58 | $230 |
| Osaic Holdings, Inc. | 0.00% | New | 26 | $103 |
| Bank of America Corp. | 0.00% | New | 10 | $40 |
| SBI Securities Co., Ltd. | 0.00% | New | 6 | $24 |
"% of holder's portfolio" is HCWB's weight in each manager's 13F, not the share of HCW Biologics Inc. the manager owns.